Stock Scorer

DNA X, Inc. (SONM)

DNA X, Inc. reported revenue of 16.2M USD for the quarter ending 30 September 2025, up 7.9% from 15M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q3 '25 · ending 30 September 2025 16.2M +7.9%
Gross Profit Q3 '25 · ending 30 September 2025 1.8M -57.1%
Operating Income Q2 '26 · ending 30 June 2026 -1.3M —
Net Income Q2 '26 · ending 30 June 2026 -1.2M —
Cost of Revenue Q3 '25 · ending 30 September 2025 14.4M +33.4%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -2M —
Free Cash Flow Q4 '24 · ending 31 December 2024 -4.5M —
Shares Outstanding Q2 '26 · ending 30 June 2026 1.4M +316.4%
EPS Q2 '26 · ending 30 June 2026 -10.18 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20242024-12-31 50.9M-3.1M-33.6M-8.7M
20232023-12-31 93.6M513K-90K-4.1M
20222022-12-31 69.8M-14.3M-14.1M-12.4M
20212021-12-31 54.6M-38M-38.6M-38.5M
20202020-12-31 64M-29.3M-29.9M-10.6M
20192019-12-31 116.3M-22.4M-25.8M-34.5M
20182018-12-31 135.7M5.4M1.3M3.1M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q3 '252025-09-3016.2M
Q2 '252025-06-3011.2M
Q1 '252025-03-3116.7M
Q4 '242024-12-3115.3M
Q3 '242024-09-3015M
Q2 '242024-06-3011.5M
Q1 '242024-03-319.1M
Q4 '232023-12-3113.4M
Q3 '232023-09-3027.6M
Q2 '232023-06-3026.8M
Q1 '232023-03-3125.8M
Q4 '222022-12-3124.1M
Q3 '222022-09-3020.5M
Q2 '222022-06-3012M
Q1 '222022-03-3113.3M
Q4 '212021-12-3115.9M
Q3 '212021-09-3014.4M
Q2 '212021-06-3012M
Q1 '212021-03-3112.2M
Q4 '202020-12-3115.8M

Gross Profit Quarterly

PeriodEndingGross Profit
Q3 '252025-09-301.8M
Q2 '252025-06-30845K
Q1 '252025-03-318.4M
Q4 '242024-12-31-183K
Q3 '242024-09-304.2M
Q2 '242024-06-303M
Q1 '242024-03-312.9M
Q4 '232023-12-315.1M
Q3 '232023-09-305.6M
Q2 '232023-06-304.4M
Q1 '232023-03-314.2M
Q4 '222022-12-313.9M
Q3 '222022-09-303.3M
Q2 '222022-06-302.8M
Q1 '222022-03-311.5M
Q3 '212021-09-301.8M
Q2 '212021-06-302.7M
Q1 '212021-03-312.5M
Q4 '202020-12-313.7M
Q3 '202020-09-304.4M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-1.3M
Q1 '262026-03-31-3.6M
Q4 '252025-12-31915K
Q3 '252025-09-30-4M
Q2 '252025-06-30-1.5M
Q1 '252025-03-31-870K
Q4 '242024-12-318.4M
Q3 '242024-09-30-2.4M
Q2 '242024-06-30-6.5M
Q1 '242024-03-31-2.7M
Q3 '232023-09-30688K
Q2 '232023-06-30747K
Q1 '232023-03-31333K
Q4 '222022-12-31-1.1M
Q3 '222022-09-30-1.9M
Q2 '222022-06-30-4.2M
Q1 '222022-03-31-7.1M
Q4 '212021-12-31-11.7M
Q3 '212021-09-30-10.7M
Q2 '212021-06-30-6.5M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-1.2M
Q1 '262026-03-316.3M
Q4 '252025-12-31-8.9M
Q3 '252025-09-30-4.8M
Q2 '252025-06-30-7.5M
Q1 '252025-03-31458K
Q4 '242024-12-31-21.6M
Q3 '242024-09-30-2.5M
Q2 '242024-06-30-6.6M
Q1 '242024-03-31-2.9M
Q3 '232023-09-30527K
Q2 '232023-06-30509K
Q1 '232023-03-31227K
Q4 '222022-12-31-1M
Q3 '222022-09-30-1.6M
Q2 '222022-06-30-4.2M
Q1 '222022-03-31-7.2M
Q4 '212021-12-31-11.7M
Q3 '212021-09-30-10.9M
Q2 '212021-06-30-6.7M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q3 '252025-09-3014.4M
Q2 '252025-06-3010.3M
Q1 '252025-03-318.4M
Q4 '242024-12-3115.2M
Q3 '242024-09-3010.8M
Q2 '242024-06-308.5M
Q1 '242024-03-3113.9M
Q4 '232023-12-318.3M
Q3 '232023-09-3022M
Q2 '232023-06-3022.4M
Q1 '232023-03-3121.6M
Q4 '222022-12-3120.2M
Q3 '222022-09-3017.2M
Q2 '222022-06-309.1M
Q1 '222022-03-3111.7M
Q4 '212021-12-3116.4M
Q3 '212021-09-3012.7M
Q2 '212021-06-309.3M
Q1 '212021-03-319.8M
Q4 '202020-12-3112.1M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-2M
Q1 '262026-03-31-3.5M
Q4 '252025-12-31-2M
Q3 '252025-09-30-7M
Q2 '252025-06-30-4.9M
Q1 '252025-03-31-9.6M
Q4 '242024-12-31-4.5M
Q3 '242024-09-30-417K
Q2 '242024-06-30-3.4M
Q1 '242024-03-31-168K
Q4 '232023-12-31-351K
Q3 '232023-09-30-304K
Q2 '232023-06-30820K
Q1 '232023-03-31-4.2M
Q4 '222022-12-31-2.2M
Q3 '222022-09-30-10.3M
Q2 '222022-06-30765K
Q1 '222022-03-31-609K
Q4 '212021-12-31-17.6M
Q3 '212021-09-30-5.7M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '242024-12-31-4.5M
Q3 '242024-09-30-554K
Q2 '242024-06-30-3.4M
Q1 '242024-03-31-198K
Q4 '232023-12-31-363K
Q3 '232023-09-30-305K
Q4 '222022-12-31-2.2M
Q3 '222022-09-30-10.3M
Q2 '222022-06-30762K
Q1 '222022-03-31-612K
Q4 '212021-12-31-17.6M
Q3 '202020-09-30-6.4M
Q2 '202020-06-304.6M
Q1 '202020-03-31891K
Q4 '192019-12-31-4.8M
Q3 '192019-09-305.3M
Q2 '192019-06-30-30.4M
Q1 '192019-03-31-4.6M
Q4 '182018-12-315.6M
Q3 '182018-09-302.7M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-301.4M
Q1 '262026-03-311.3M
Q3 '252025-09-30984.9K
Q2 '252025-06-30528.4K
Q1 '252025-03-31324.4K
Q3 '242024-09-30269.4K
Q2 '242024-06-304.7M
Q1 '242024-03-314.4M
Q3 '232023-09-304.4M
Q2 '232023-06-304.5M
Q1 '232023-03-3141.1M
Q3 '222022-09-3036.1M
Q2 '222022-06-3019.3M
Q1 '222022-03-3119.1M
Q3 '212021-09-308.4M
Q2 '212021-06-306.7M
Q1 '212021-03-316.6M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-10.18
Q1 '262026-03-31-23.41
Q4 '252025-12-31-27.01
Q3 '252025-09-30-99.44
Q2 '252025-06-30-103.93
Q1 '252025-03-31-91.19
Q4 '242024-12-31-93.25
Q3 '232023-09-300.39
Q2 '232023-06-300.23
Q1 '232023-03-31-0.10
Q4 '222022-12-31-0.49
Q3 '222022-09-30-1.00
Q2 '222022-06-30-2.27
Q1 '212021-03-31-3.12
Q4 '202020-12-31-2.20
Q3 '202020-09-30-2.10
Q2 '202020-06-30-1.45
Q1 '202020-03-31-1.54
Q4 '192019-12-31-1.38
Q3 '192019-09-308.16